New drug trial aims to rescue failing kidneys
NCT ID NCT07161843
Summary
This study is testing whether an experimental drug called QRX-3 can help hospitalized patients with a specific type of sudden kidney failure called acute tubular necrosis. It will compare QRX-3 plus standard care against a placebo plus standard care in 500 patients. The main goal is to see if the drug helps improve how quickly the kidneys filter waste from the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RENAL FAILURE (ARF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neukidney Inc
Rosharon, Texas, 77583, United States
Conditions
Explore the condition pages connected to this study.